Research progress of feline infectious peritonitis and feasibility analysis of new drug development
Feline infectious peritonitis(FIP),a highly fatal feline disease caused by feline coronavirus(FCoV)mutations,was once considered incurable due to the lack of effective drugs to treat it.The Novel Coronavirus Pneumonia(COVID-19)epidemic has accelerated the research process of anti-coronavirus drugs.In recent years,a number of drugs have been approved for the treatment of COVID-19 by adding new indications,and to some extent,remarkable effects have been achieved.The progress of medical research has also brought new directions for the treatment of FIP in the veterinary field.This article summarizes the epidemiology of FIP and the current main treatment options,and then discusses the internal relationship between several anti-COVID-19 drugs and feline infectious peritonitis virus(FIPV)from the perspective of antiviral mechanism,in order to provide references for the development of new drugs for clinical treatment of FIP.
CoronavirusFeline coronavirusFeline infectious peritonitisNew drug research and development